Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MPN Advances Day 2019 | Avapritinib updates in advanced systemic mastocytosis: EXPLORER and PIONEER

Mark Drummond • 15 Nov 2019
MPN Advances Day 2019
Myeloproliferative Neoplasms Systemic Mastocytosis Avapritinib
EXPLORER PIONEER

Mark Drummond, MB ChB, PhD, FRCPath, Beatson West of Scotland Cancer Centre, Glasgow, UK, discusses the novel therapies for systemic mastocytosis. He explains the results thus far for the EXPLORER trial of avapritinib in patients with advanced symstemic mastocytosis (NCT02561988), and mentions the upcoming PIONEER trial (NCT03731260). This interview took place at the Myeloproliferative Neoplasms Conference 2019 in London, UK.

Related Videos

2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
2:52
JAK inhibitor combination therapy for the treatment of myelofibrosis
Ruben Mesa • 9 Dec 2023
1:30
XPORT-MF-034: selinexor + ruxolitinib combination therapy for MF
John Mascarenhas • 10 Dec 2023
1:38
Pelabresib plus ruxolitinib for the treatment of intermediate- and high-risk myelofibrosis
John Mascarenhas • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals